When we assessed the effects of PSMD3 knockdown on NF-κB luciferase activity in FLT3+ AML, we observed minimal changes (Figure 4B), suggesting that additional signaling pathways are regulated by PSMD3 expression in this particular disease. This evidence concerns the gene NFKB1 and acute myeloid leukemia.